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EDITORIAL COMMENT
The Bubbles and the Science
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Paolo Voci, MD, PHD
Rome, Italy
Born in 1968, contrast echocardiography has already passed
its third decade of life but, after a promising debut (1,2), has
never achieved routine clinical use. Differing from two-
dimensional echocardiography and color-Doppler, which
rapidly became the “prima donna” in cardiac imaging,
contrast echocardiography followed a desultory nonlinear
evolution, as erratic as the bizarre response of the bubbles
themselves to ultrasound, with disillusion often following
enthusiasm (3). These alternating fortunes were largely due
to the complex physics of the bubbles, and the negative
connotation of the word “bubble” itself mirrors our igno-
rance about the interaction between these agents and
ultrasound. It is, therefore, not surprising that we had to
wait 25 years before noninvasively obtaining myocardial
opacification, first with transesophageal echocardiography
and triggered end-systolic imaging (4) and later with trans-
thoracic harmonic imaging (5–7). What basically retarded
the technique for a long time was a “complex of stability,”
inherent in the volatile nature of the bubbles. In the baroque
iconography, the vanishing and unstable nature of life is
often represented as bubbles between a putto and a skull
See page 618
(Fig. 1). Fortunately, the stability of the bubbles has been
recently improved with the use of gases of low-diffusability
instead of air (5). This new generation of bubbles survives
the stress of systemic circulation, may be used to trace vital
flow, and promises to rehabilitate the discipline of contrast
echocardiography.
The article by Villanueva and associates (8) is a well-
conducted experimental study, showing the potential of con-
trast echocardiography to detect progressive growth of collat-
eral flow during chronic coronary occlusion in the dog. The
authors propose contrast echocardiography as a clinical tool to
monitor collateral flow growth after therapeutic angiogenesis, a
promising new technique to treat chronic ischemia. The results
shown in this model, while impressive, demand a note of
caution before considering this technique for use in humans. In
my opinion there are six points to focus on to define the
remaining hurdles to clinical use.
The complex physiology of collateral flow. Collateral
circulation develops distal to a flow-limiting coronary ste-
nosis and depends on the degree of the stenosis and
metabolic requirements of the underlying myocardium. In
patients with chronic, stable angina, well-developed collat-
eral vessels ensure homogenous myocardial perfusion at rest.
However, collaterals differ in terms of anatomy and flow
pattern from normal arterial vessels because they are char-
acterized by marked endothelial cell proliferation and sub-
intimal hyperplasia (9). Thus, a well-developed collateral
circulation represents a resistance to blood flow that is
functionally comparable with a severe stenosis of a native
coronary artery (10). As the microbubbles preferentially
follow low-resistance flow, we cannot, a priori, assume that
they can accurately depict high-resistance flow.
Imaging projection. The authors used a short-axis projec-
tion, which has the advantage of including all the three
coronary artery beds but excludes the apex, an extremely
important region during anterior myocardial infarction. In
anterior infarction, apical views provide copious information
about reperfusion (7,11) and prognosis. In any case, in
humans, myocardial opacification is difficult to achieve in
the short-axis view, while it is successful in apical projec-
tions (6,7).
Off-line analysis. The technique described in this paper
requires a time consuming, and possibly biasing, off-line
analysis. Ovidius, in his Ars Amandi, wrote, “Medicine is
above all the art of timeliness” (Temporis ars medicina fere
est). We may paraphrase Ovidius by saying, “Echocardiog-
raphy is the art of real-time imaging” and should remain this
way to provide the best and most reliable results.
Feasibility of quantitative assessment of flow. The quan-
titative assessment of flow has been proposed for many years
in experimental models (12–15), but it remained a chimera
of contrast echocardiography. The application of the
indicator-dilution theory is precluded not only because of
microbubble destruction (8) but also because there are many
other variables that make the in vivo response to the
microbubbles largely unpredictable. Among those, I would
like to mention the fluctuant resonance frequency during
the cardiac cycle, the wide variation in reflectivity with small
changes in bubble diameter, the heterogeneous response to
different acoustic fields and the wide variations in backscat-
ter with small changes in the angle of the ultrasound beam.
Triggering modality. The microbubbles are destroyed (or
most probably change in shape and, therefore, reflectivity)
when exposed to an ultrasound field. This is one of the
reasons why we have proposed triggered imaging to improve
detection of myocardial perfusion (4). However, an im-
proper triggering may produce illusionary normal perfusion
in ischemic or even nonviable territories. To detect physi-
ologic changes in microvascular flow, triggering should be
restricted to one cardiac cycle, but in most laboratories up to
1:8 triggering intervals are used in an effort to obtain
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myocardial opacification. The authors of the present study
fail to describe triggering interval, and, therefore, we have to
assume they have used a 1:4 interval, as in other similar
experimental settings. In my opinion this interval may be
too long to differentiate normal from pathologic flow. As
flow velocity in the capillaries is 0.3 mm/s at rest and the
capillaries are 0.3 to 1 mm in length, the microbubbles are
likely to traverse the microcirculation in 1 to 3 s. It derives
that 1:1 triggering (4,7) (or better, continuous imaging)
should better detect temporal heterogeneity in myocardial
perfusion. It should also be considered that even nonviable
segments maintain a certain degree of vascularization, which
is characterized by slow and low flow. The microbubbles
may pool in these regions, and prolonged triggered imaging
may produce a false positive pattern of adequate perfusion.
On the other hand, a 1:1 trigger, producing better “bubble
destruction” in slow flow regions, may show false negative
perfusion in still-viable segments.
Technical maze. The uncertainty about the optimal tech-
nique to obtain myocardial opacification involves not only
the triggering interval but virtually all the modalities and
settings of the ultrasound machine (Table 1). It is still
debated whether we have to use an infusion or bolus
injection, which transducer frequency, which mechanical
index and pulse repetition frequency and which imaging
modality (harmonic, power Doppler or pulse inversion).
Lastly, attenuation, that is, the shadowing produced by the
contrast agent itself, is a major unresolved problem because
the dose necessary to obtain optimal perfusion is still too
close to that producing the artifact.
Conclusion and future developments. In the last six years
the clinician has perceived the important message that
noninvasive myocardial opacification is a reality, and, re-
cently, a widespread “perfusion fever” has developed with a
largely irrational rush to obtain ready-to-use equipment.
However, reality is more complex, and the clinician should
be aware that a lot of work remains to be done before
extending the data obtained in leading centers to routine
clinical practice (6).
Nonetheless, there are some important areas in which
contrast echocardiography is ready for use and may provide
sound clinical information: 1) the evaluation of the infarct
zone and reperfusion after acute myocardial infarction (7);
2) improving the accuracy of transesophageal echocardiog-
raphy in the detection of the left atrial appendage thrombi
(16); 3) the noninvasive color-Doppler imaging of the
coronary arteries (17,18) with applications to coronary flow
reserve, postinfarction reperfusion (11) and coronary vaso-
motion (19); 4) the early detection of false lumen perfusion
during repair of aortic dissection, to decrease risk of intra-
operative central nervous system damage and death (20); 5)
imaging of intracranial vessels and other unexplored terri-
tories such as the arterial supply to the spinal cord (21).
From this perspective, we may re-interpret the apparently
negative classical iconography (Fig. 1) and promote the best
qualities of the microbubbles as tracers of vital flow, dis-
closing new secrets of biology, the science of life.
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Figure 1. “Quis evadet?” (Who can escape?). Copper engraving (1594) by
Hendrick Goltzius (Muehlbracht 1558—Haarlem 1617) Allegorie der
Vergaenglichkeit (Allegory of fleetness) 193 3 153 mm. Staatliche
Museum Preussischer Kulturbesitz, Kupferstichkabinett. Berlin. Courtesy
of Judikje Kiers, Rijksmuseum, Amsterdam, Holland.
Table 1. Unresolved Technical Issues in
Contrast Echocardiography
Stable or unstable bubbles
Dose and concentration of the bubbles
Bolus or infusion
Resonance frequency
To trigger or not to trigger
Triggering interval








Digital subtraction or real-time analysis
Attenuation
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